Benitec Biopharma Appoints New CMO, Adds Directors
Ticker: BNTC · Form: 8-K · Filed: Mar 8, 2024 · CIK: 1808898
| Field | Detail |
|---|---|
| Company | Benitec Biopharma INC. (BNTC) |
| Form Type | 8-K |
| Filed Date | Mar 8, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 B, $5.21 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-of-directors, executive-appointment
TL;DR
Benitec Biopharma shakes up leadership: new CMO, two new directors, one CMO departs.
AI Summary
Benitec Biopharma Inc. announced on March 6, 2024, the appointment of Dr. Joseph S. Carillo as Chief Medical Officer and the election of Ms. Jennifer L. D. Allison and Mr. David S. Wood to its Board of Directors. The company also reported the departure of Dr. B.K. Singh from his role as Chief Medical Officer. These changes are effective immediately.
Why It Matters
These executive and board changes could signal a shift in the company's strategic direction or operational focus in the biopharmaceutical sector.
Risk Assessment
Risk Level: medium — Changes in key executive and board positions can introduce uncertainty regarding future strategy and execution.
Key Players & Entities
- Benitec Biopharma Inc. (company) — Registrant
- Dr. Joseph S. Carillo (person) — Appointed Chief Medical Officer
- Ms. Jennifer L. D. Allison (person) — Elected to Board of Directors
- Mr. David S. Wood (person) — Elected to Board of Directors
- Dr. B.K. Singh (person) — Departed Chief Medical Officer
- March 6, 2024 (date) — Effective date of changes
FAQ
Who has been appointed as the new Chief Medical Officer?
Dr. Joseph S. Carillo has been appointed as the new Chief Medical Officer.
Who were elected to the Board of Directors?
Ms. Jennifer L. D. Allison and Mr. David S. Wood were elected to the Board of Directors.
Who has departed from their role as Chief Medical Officer?
Dr. B.K. Singh has departed from his role as Chief Medical Officer.
What is the effective date of these changes?
The changes are effective as of March 6, 2024.
What is the principal executive office address of Benitec Biopharma Inc.?
The principal executive office address is 3940 Trust Way, Hayward, California 94545.
Filing Stats: 535 words · 2 min read · ~2 pages · Grade level 12.2 · Accepted 2024-03-08 16:17:00
Key Financial Figures
- $0.0001 B — ich registered Common Stock, par value $0.0001 BNTC The Nasdaq Stock Market LLC Indic
- $5.21 — ns were granted at an exercise price of $5.21 per share, which equals the closing pri
Filing Documents
- d782153d8k.htm (8-K) — 23KB
- 0001193125-24-063667.txt ( ) — 138KB
- bntc-20240306.xsd (EX-101.SCH) — 3KB
- bntc-20240306_lab.xml (EX-101.LAB) — 17KB
- bntc-20240306_pre.xml (EX-101.PRE) — 11KB
- d782153d8k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. BENITEC BIOPHARMA INC. Date: March 8, 2024 By: /s/ Dr. Jerel A. Banks Name: Dr. Jerel A. Banks Title: Chief Executive Officer